Rapamycin derivatives for treating neuroblastoma

Details for Australian Patent Application No. 2007217705 (hide)

Owner Novartis AG

Inventors Schaller, Hans

Agent Davies Collison Cave

Pub. Number AU-A-2007217705

PCT Pub. Number WO2007/096174

Priority 0603782.4 24.02.06 GB

Filing date 22 February 2007

Wipo publication date 30 August 2007

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/096174 Priority application(s): WO2007/096174

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217715-Polypeptides with laccase activity

2007217704-Combinations of steroids and methylxanthine compounds